Product Overview
[Drug Name]
Trade Name: Xianning
English Name: Lansoprazole Tablets
Chinese Pinyin: Lansuolazuo pian
[Ingredients]
Lansoprazole.
[Properties]
This product is a white enteric-coated tablet that appears white or off-white after removal of the enteric coating.
[Indications]
Gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome (gastrinoma).
[Dosage and Administration]
For duodenal ulcers, adults should generally take 15-30 mg of lansoprazole orally once daily for 4-6 weeks. For gastric ulcers, reflux esophagitis, Zollinger-Ellison syndrome, and anastomotic ulcers, adults should generally take 30 mg of lansoprazole orally once daily for 6-8 weeks. However, for maintenance therapy, elderly patients, patients with liver dysfunction, or patients with renal impairment, 15 mg of lansoprazole should be taken orally once daily.
[Adverse Reactions]
1. Allergic Reactions: Occasionally, symptoms such as rash and itching may occur. Discontinue use if these symptoms occur.
2. Liver: Occasionally, elevated levels of GOT, GPT, ALP, LDH, and γ-GTP may occur. Careful observation is required. If any abnormalities are detected, appropriate measures such as discontinuation of the drug should be taken.
3. Blood: Occasionally, symptoms such as anemia, leukopenia, and eosinophilia may occur. Thrombocytopenia rarely occurs.
4. Digestive System: Occasionally, symptoms such as constipation, diarrhea, thirst, and abdominal distension may occur.
5. Neuropsychiatric System: Occasionally, symptoms such as headache and drowsiness may occur. Insomnia and dizziness rarely occur.
6. Other: Occasionally, fever, elevated total cholesterol, and elevated uric acid may occur.
[Contraindications]
This product is contraindicated in patients who are allergic to it.
[Precautions]
1. During treatment, patients should be fully observed and the minimum dose required for treatment should be used according to their symptoms.
2. Use with caution in the following patients:
(1) Patients with a history of drug allergies
(2) Patients with liver dysfunction
(3) Elderly patients: Generally speaking, the gastric acid secretion capacity and other physiological functions of elderly patients are reduced, so please pay attention to observation during medication.
[Special population use]
Precautions for children:
The safety of this product for children has not yet been established (there is very little clinical experience in children).
Precautions for pregnancy and lactation:
Pregnant and lactating women should not use this product.
Precautions for the elderly:
Generally speaking, the gastric acid secretion capacity and other physiological functions of elderly patients are reduced, so please pay attention to observation during medication.
[Drug interactions]
It will delay the metabolism and excretion of diazepam and phenytoin sodium. This data has been published in reports on similar drugs such as omeprazole.
[Pharmacological Action]
This product is a novel drug that inhibits gastric acid secretion. It acts on the H+-K+-ATPase enzyme in gastric parietal cells, preventing H+ from being transported into the stomach, significantly reducing the amount of gastric acid in gastric juice. It is clinically used to treat duodenal ulcers, gastric ulcers, reflux esophagitis, and Zollinger-Ellison syndrome (gastrinoma) with significant efficacy. It also has inhibitory effects on Helicobacter pylori.
[Storage]
Store in a cool, dark, and dry place, protected from light.
[Strength]
15 mg
[Packaging]
15 mg x 14 sachets/box
[Expiry Life]
24 months.
[Approval Number]
National Medicine Standard No. H20103038
[Manufacturer]
Company Name: Suzhou Dawnray Pharmaceutical Co., Ltd.
